SUBSCRIBE: Print / eNewsletter
Novel Antibody Improves Survival in Advanced Gastric Cancer
A novel first-in-class antibody can significantly extend median survival when added to standard chemotherapy for patients with advanced gastric cancer.
Long-Term AI Therapy Reduces Breast Cancer Recurrence
Postmenopausal women with early breast cancer benefit from extending AI therapy with letrozole from 5 to 10 years, and show no worsening of quality of life.
Quality of Life Could Help Select Treatment for Soft-Tissue Sarcoma
Understanding quality of life and the detrimental impact of disease progression is critical for long-term care and survival of patients with soft-tissue sarcoma.
Antibody Drug Conjugate Shows Promise in Small-Cell Lung Cancer
An antibody-drug conjugate, rovalpituzumab tesirine, shows promising efficacy against recurrent small-cell lung cancer.
Warfarin Another Option for Cancer-Associated Thrombosis
Warfarin is an acceptable alternative to low-molecular-weight heparin for patients with cancer-associated thrombosis, according to a new study.
Real-Time Classification Finds High-Risk ALL With Favorable Outcomes
Real-time classification can identify a previously unrecognized subset of high-risk patients with childhood B-cell acute lymphoblastic leukemia who have excellent chances for cure without further intensification of treatment.
Guidelines Validated for Anticoagulant Dose Reductions in Thrombocytopenia
A new study validates therapeutic guidelines that recommend anticoagulant dose reductions for thrombocytopenia in cancer patients.
Many Children With ALL Do Not Take Medicine as Directed
Children with acute lymphocytic leukemia and their parents commonly over-report the amount of daily oral chemotherapy the child takes to treat the most common blood cancer in children.
Engineered CAR T Cells Show Promise in Multiple Myeloma
Chimeric antigen receptor T cells can eradicate large burdens of multiple myeloma, according to a new study presented at ASH.
Genetic Risk Factors Affect Osteonecrosis Development in Pediatric ALL
Genetic variants increase the risk of osteonecrosis in children under age 10 with acute lymphoblastic leukemia.